| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | CFO AND COO | Common Stock | 79.8K | $90.1K | $1.13 | Aug 5, 2024 | Direct |
| MARINUS PHARMACEUTICALS, INC. | CFO AND COO | Stock Option (Right to Buy) | 57.3K | Jun 18, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MRNS | MARINUS PHARMACEUTICALS, INC. | Aug 5, 2024 | 1 | -$5.26K | 4 | Aug 7, 2024 | CFO AND COO |
| MRNS | MARINUS PHARMACEUTICALS, INC. | Jun 18, 2024 | 2 | $0 | 4 | Jun 20, 2024 | CFO AND COO |
| MRNS | MARINUS PHARMACEUTICALS, INC. | Feb 16, 2024 | 1 | -$30.8K | 4 | Feb 21, 2024 | CFO AND COO |
| MRNS | MARINUS PHARMACEUTICALS, INC. | Jan 18, 2024 | 2 | $0 | 4 | Jan 19, 2024 | CFO AND COO |
| MRNS | MARINUS PHARMACEUTICALS, INC. | Aug 7, 2023 | 2 | -$26.7K | 4 | Aug 8, 2023 | CFO AND COO |
| MRNS | MARINUS PHARMACEUTICALS, INC. | Jan 26, 2023 | 2 | $0 | 4 | Jan 30, 2023 | CHIEF FINANCIAL OFFICER |
| MRNS | MARINUS PHARMACEUTICALS, INC. | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Chief Financial Officer |
| MRNS | MARINUS PHARMACEUTICALS INC | Feb 4, 2022 | 2 | $0 | 4 | Feb 7, 2022 | Chief Financial Officer |